Literature DB >> 18175032

The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.

Ming Ding1, Carl Christian Danielsen, Ivan Hvid.   

Abstract

We assessed whether increase of subchondral bone density enhances cartilage stress during impact loading, leading to progressive cartilage degeneration and accelerated osteoarthrosis (OA) progression. Sixty-six male guinea pigs were randomly divided into six groups. During a 9-week treatment period, four groups received twice-weekly subcutaneous injections of alendronate (ALN) in two doses: two groups received 10 microg/kg and two groups received 50 microg/kg. The two control groups received vehicle. After 9 weeks, one 10 microg/kg ALN group, one 50 microg/kg ALN group, and one control group were killed. The remaining three groups (17-week groups) were left for an additional 8 weeks, receiving the same treatment regimen before death. The left proximal tibiae were scanned by micro-computed tomography to quantify the microarchitecture of subchondral bone, followed by mechanical testing and determination of collagen and mineral. The control groups had typical OA-related cartilage degeneration at 9 and 17 weeks, whereas the 50 microg/kg ALN group had even worse degeneration in the medial condyle. It is unclear whether there is a direct or a secondary effect of ALN on the cartilage. The 9-week ALN group had significantly greater subchondral plate thickness. The 9- and 17-week groups had similar changes of cancellous bone microarchitecture, with greater volume fraction and connectivity and an extremely plate-like structure. The 9-week ALN group had greater bone mineral concentration, and the 17-week ALN group had reduced collagen concentration and greater mineral concentration. Treatment with ALN did not significantly change the mechanical properties of the cancellous bone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175032     DOI: 10.1007/s00223-007-9093-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  18 in total

1.  Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain.

Authors:  Shouan Zhu; Jianxi Zhu; Gehua Zhen; Yihe Hu; Senbo An; Yusheng Li; Qin Zheng; Zhiyong Chen; Ya Yang; Mei Wan; Richard Leroy Skolasky; Yong Cao; Tianding Wu; Bo Gao; Mi Yang; Manman Gao; Julia Kuliwaba; Shuangfei Ni; Lei Wang; Chuanlong Wu; David Findlay; Holger K Eltzschig; Hong Wei Ouyang; Janet Crane; Feng-Quan Zhou; Yun Guan; Xinzhong Dong; Xu Cao
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

Review 2.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

3.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig.

Authors:  V B Kraus; J L Huebner; J DeGroot; A Bendele
Journal:  Osteoarthritis Cartilage       Date:  2010-10       Impact factor: 6.576

4.  Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis.

Authors:  Liu Zhang; Hongyu Hu; Faming Tian; Huiping Song; Yingze Zhang
Journal:  Clin Exp Med       Date:  2011-02-09       Impact factor: 3.984

5.  Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion.

Authors:  Chao Fang; Jia-Wei Guo; Ya-Jun Wang; Xiao-Qun Li; Hao Zhang; Jin Cui; Yan Hu; Ying-Ying Jing; Xiao Chen; Jia-Can Su
Journal:  Acta Pharmacol Sin       Date:  2021-08-11       Impact factor: 7.169

6.  Biomechanics of the Femoral Head Cartilage and Subchondral Trabecular Bone in Osteoporotic and Osteopenic Fractures.

Authors:  Mahmut Pekedis; Firat Ozan; Hasan Yildiz
Journal:  Ann Biomed Eng       Date:  2021-09-01       Impact factor: 3.934

7.  Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis.

Authors:  Yubo Sun; Nikkole Haines; Andrea Roberts; Michael Ruffolo; David R Mauerhan; Kim L Mihalko; Jane Ingram; Michael Cox; Edward N Hanley
Journal:  BMC Musculoskelet Disord       Date:  2015-09-30       Impact factor: 2.362

8.  Subchondral bone plate thickening precedes chondrocyte apoptosis and cartilage degradation in spontaneous animal models of osteoarthritis.

Authors:  Zaitunnatakhin Zamli; Kate Robson Brown; John F Tarlton; Mike A Adams; Georgina E Torlot; Charlie Cartwright; William A Cook; Kristiina Vassilevskaja; Mohammed Sharif
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

9.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

10.  Biological activities of phosphocitrate: a potential meniscal protective agent.

Authors:  Yubo Sun; Andrea Roberts; David R Mauerhan; Andrew R Sun; H James Norton; Edward N Hanley
Journal:  Biomed Res Int       Date:  2013-07-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.